NCT04359186View on ClinicalTrials.gov

SCOPE Analytic Treatment Interruption Protocol

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2026

Conditions
HIV/AIDS
Interventions
OTHER

Treatment Interruption Arm

Individuals with HIV on suppressive ART will interrupt their ART.

Trial Locations (1)

94110

RECRUITING

University of California San Francisco, San Francisco

All Listed Sponsors
collaborator

Chan Zuckerberg Biohub

OTHER

lead

University of California, San Francisco

OTHER